Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Receivables - Other (2017 - 2022)

Historic Receivables - Other for Aspen Aerogels (ASPN) over the last 8 years, with Q4 2022 value amounting to $143000.0.

  • Aspen Aerogels' Receivables - Other fell 9219.01% to $143000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $143000.0, marking a year-over-year decrease of 9219.01%. This contributed to the annual value of $143000.0 for FY2022, which is 9219.01% down from last year.
  • According to the latest figures from Q4 2022, Aspen Aerogels' Receivables - Other is $143000.0, which was down 9219.01% from $1.4 million recorded in Q3 2022.
  • In the past 5 years, Aspen Aerogels' Receivables - Other ranged from a high of $6.6 million in Q2 2019 and a low of $143000.0 during Q4 2022
  • Its 5-year average for Receivables - Other is $2.1 million, with a median of $1.8 million in 2020.
  • As far as peak fluctuations go, Aspen Aerogels' Receivables - Other soared by 174507.04% in 2019, and later crashed by 9219.01% in 2022.
  • Aspen Aerogels' Receivables - Other (Quarter) stood at $3.1 million in 2018, then plummeted by 53.81% to $1.4 million in 2019, then grew by 27.42% to $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021, then tumbled by 92.19% to $143000.0 in 2022.
  • Its Receivables - Other was $143000.0 in Q4 2022, compared to $1.4 million in Q3 2022 and $2.7 million in Q2 2022.